tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market
PMCB
PharmaCyte Biotech
RESEARCH TOOLSreports
Want to see PMCB full AI Analyst Report?

PharmaCyte Biotech (PMCB) Income Statement

262 Followers

PharmaCyte Biotech Income Statement

Last quarter (Q3 2026), PharmaCyte Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, PharmaCyte Biotech's net income was $746.86K. See PharmaCyte Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Apr 25Apr 24Apr 23Apr 22Apr 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.38M$ 6.52M$ 6.46M$ 4.39M$ 3.62M
Depreciation and Amortization
$ 0.00$ 6.52M$ 6.46M$ 0.00$ 0.00
EBITDA
$ 30.66M$ 6.85M$ -4.32M$ -4.24M$ -3.55M
Operating Income
$ -4.38M$ -6.52M$ -6.46M$ -4.39M$ -3.62M
Other Income/Expenses
$ 35.03M$ 6.85M$ 2.14M$ 152.85K$ 71.75K
Pretax Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Net Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Per Share Metrics
Basic EPS
$ 3.19$ -1.80$ -0.22$ -0.27$ -2.46
Diluted EPS
$ 3.19$ -1.80$ -0.83$ -0.79$ -2.46
Weighted Average Shares Outstanding
 7.33M 9.58M 19.49M 15.52M 1.45M
Weighted Average Shares Outstanding (Diluted)
 7.33M 9.58M 5.18M 5.18M 1.45M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History